Literature DB >> 23325362

Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches.

Michael Bergman1, Rachel Dankner, Jesse Roth, K M Venkat Narayan.   

Abstract

Diagnosis of dysglycemic states is likely delayed as current diagnostic criteria apply absolute threshold values to a process that is continuous. The importance of this relates to forestalling opportunities for earlier diagnosis when prevention and reversibility are more likely to occur by preventing further β cell dysfunction. Although the optimal method for earlier identification of individuals at risk remains uncertain, the paper suggests novel approaches.

Mesh:

Substances:

Year:  2013        PMID: 23325362     DOI: 10.1007/s12020-013-9873-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  20 in total

Review 1.  The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention.

Authors:  Rachel Dankner; Michael Bergman; Ann Danoff; Sana Qureshi; Ian Whitford; Nargess Kaviani; Yevgeniya Dynkevich; Jesse Roth
Journal:  Diabetes Metab Res Rev       Date:  2013-01       Impact factor: 4.876

2.  Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).

Authors:  Y Heianza; Y Arase; K Fujihara; H Tsuji; K Saito; S D Hsieh; S Kodama; H Shimano; N Yamada; S Hara; H Sone
Journal:  Diabet Med       Date:  2012-09       Impact factor: 4.359

3.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

4.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

5.  Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study.

Authors:  Maren Carstensen; Christian Herder; Mika Kivimäki; Markus Jokela; Michael Roden; Martin J Shipley; Daniel R Witte; Eric J Brunner; Adam G Tabák
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

6.  Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.

Authors:  Chutima Talchai; Shouhong Xuan; Hua V Lin; Lori Sussel; Domenico Accili
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

Review 7.  Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2012-11-07       Impact factor: 3.633

8.  Inadequacies of absolute threshold levels for diagnosing prediabetes.

Authors:  Michael Bergman
Journal:  Diabetes Metab Res Rev       Date:  2010-01       Impact factor: 4.876

9.  Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.

Authors:  Adam G Tabák; Maren Carstensen; Daniel R Witte; Eric J Brunner; Martin J Shipley; Markus Jokela; Michael Roden; Mika Kivimäki; Christian Herder
Journal:  Diabetes Care       Date:  2012-08-28       Impact factor: 19.112

10.  Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006.

Authors:  Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  8 in total

1.  Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

Authors:  Michael Bergman; Ram Jagannathan; Martin Buysschaert; Jose Luis Medina; Mary Ann Sevick; Karin Katz; Brenda Dorcely; Jesse Roth; Angela Chetrit; Rachel Dankner
Journal:  Endocrine       Date:  2017-01-25       Impact factor: 3.633

2.  Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus.

Authors:  Jean Huang; Horng-Yih Ou; Rudruidee Karnchanasorn; Raynald Samoa; Lee-Ming Chuang; Ken C Chiu; Wei Feng
Journal:  Endocrine       Date:  2014-06-04       Impact factor: 3.633

3.  Inadequacies of current approaches to prediabetes and diabetes prevention.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2013-07-24       Impact factor: 3.633

Review 4.  Prediabetes and associated disorders.

Authors:  Martin Buysschaert; José Luís Medina; Michael Bergman; Avni Shah; Jaqueline Lonier
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

Review 5.  Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Authors:  Jay S Skyler; George L Bakris; Ezio Bonifacio; Tamara Darsow; Robert H Eckel; Leif Groop; Per-Henrik Groop; Yehuda Handelsman; Richard A Insel; Chantal Mathieu; Allison T McElvaine; Jerry P Palmer; Alberto Pugliese; Desmond A Schatz; Jay M Sosenko; John P H Wilding; Robert E Ratner
Journal:  Diabetes       Date:  2016-12-15       Impact factor: 9.461

6.  Hair follicle characteristics as early marker of Type 2 Diabetes.

Authors:  J Jaime Miranda; Alvaro Taype-Rondan; Jose Carlos Tapia; Maria Gabriela Gastanadui-Gonzalez; Ricardo Roman-Carpio
Journal:  Med Hypotheses       Date:  2016-08-16       Impact factor: 4.411

7.  Relationships of serum soluble E-selectin concentration with insulin sensitivity and metabolic flexibility in lean and obese women.

Authors:  Agnieszka Adamska; Monika Karczewska-Kupczewska; Agnieszka Nikołajuk; Elżbieta Otziomek; Maria Górska; Irina Kowalska; Marek Strączkowski
Journal:  Endocrine       Date:  2013-08-10       Impact factor: 3.633

8.  Newly diagnosed type 2 diabetes in an ethnic minority population: clinical presentation and comparison to other populations.

Authors:  Michael Morkos; Bettina Tahsin; Louis Fogg; Leon Fogelfeld
Journal:  BMJ Open Diabetes Res Care       Date:  2018-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.